Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy.

Journal: Behavioural neurology

Volume: 2016

Issue: 

Year of Publication: 2017

Affiliated Institutions:  Finote Selam Hospital, Finote Selam, Ethiopia. Diseases Prevention and Control, School of Public Health, University of Queensland, Brisbane, QLD, Australia. Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia. College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. College of Health Sciences, Mizan Tepi University, Mizan, Ethiopia. Psychiatry Department, College of Health Sciences and Medicine, Dilla University, Dilla, Ethiopia. Debre Markos University, Debre Markos, Ethiopia. College of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Abstract summary 

Antiepileptic drugs are effective in the treatment of epilepsy to the extent that about 70% of people with epilepsy can be seizure-free, but poor adherence to medication is major problem to sustained remission and functional restoration. The aim of this study was to assess the prevalence and associated factors of antiepileptic drug nonadherence. Cross-sectional study was conducted on 450 individuals who were selected by systematic random sampling method. Antiepileptic drug nonadherence was measured by Morisky Medication Adherence Scale (MMAS) and logistic regression was used to look for significant associations. The prevalence of AEDs nonadherence was 37.8%. Being on treatment for 6 years and above [AOR = 3.47, 95% CI: 1.88, 6.40], payment for AEDs [AOR = 2.76, 95% CI: 1.73, 4.42], lack of health information [AOR = 2.20, 95% CI: 1.41,3.43], poor social support [AOR = 1.88, 95%, CI: 1.01, 3.50], perceived stigma [AOR = 2.27, 95% CI: 1.45, 3.56], and experience side effect [AOR = 1.70, 95% CI: 1.06, 2.72] were significantly associated with antiepileptic drug nonadherence. More than one-third of people with epilepsy were not compliant with their AEDs. Giving health information about epilepsy and its management and consequent reduction in stigma will help for medication adherence.

Authors & Co-authors:  Getnet Asmamaw A Woldeyohannes Solomon Meseret SM Bekana Lulu L Mekonen Tesfa T Fekadu Wubalem W Menberu Melak M Yimer Solomon S Assaye Adisu A Belete Amsalu A Belete Habte H

Study Outcome 

Source Link: Visit source

Statistics
Citations :  World Health Organization. Neurological Disorders: Public Health Challenges. Geneva‎, Switzerland: World Health Organization; 2006.
Authors :  10
Identifiers
Doi : 3189108
SSN : 1875-8584
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Study Design
Cross Sectional Study
Study Approach
Systemic Review
Country of Study
Publication Country
Netherlands